Zai Lab is a holding company. Through its subsidiaries, Co. is a commercial-stage biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need in the China and global markets, including in the fields of oncology, infectious and autoimmune diseases. Co.'s products are: Niraparib, a selective oral, small molecule PARP 1/2 inhibitor with the potential to be a drug for treatment across multiple solid tumor types in China; and Optune, a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die. We show 1 historical shares outstanding datapoints in our ZLAB shares outstanding history coverage, used to compute ZLAB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ZLAB market cap history over the course of time is important for investors
interested in comparing ZLAB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ZLAB versus a peer is one thing; comparing
ZLAB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ZLAB can fluctuate over the course of history.
With this page we aim to empower investors researching ZLAB by allowing them to research the ZLAB market cap history. |
Free ZLAB Email Alerts:
Video: The Importance of Market Cap
